TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 2 | 1 | 3 | 1 | 5 | 0 | -4 | -14 | -25 | -7 |
| P | %wins | 100 | 100 | 67 | 33 | 33 | 33 | 61 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/24/10 20:31 | 5/20/10 | NABI | Nabi Biopharmaceuticals | DE | Health | BioPrd | Biological Products, (No Diag | Davis Peter B | VT | D | P.d | 20 | 5.24 | 2 | 4 | 35 | 15 | D | 34 | 99 | 7 | 3 | -8 | -8 | -7 | -8 | 1 | 1 | 1 | -8 | -3 | -2 | |
11/25/09 12:58 | 11/23/09 | NABI | Nabi Biopharmaceuticals | DE | Health | BioPrd | Biological Products, (No Diag | Davis Peter B | VT | D | P | 15 | 4.98 | 3 | 3 | 38 | 11 | D | 57 | 44 | 77 | 54 | 33 | 51 | 38 | 5 | 1 | 3 | -2 | 7 | 13 | 6 | |
3/25/04 17:55 | 3/25/04 | XOMA | Xoma Ltd /de/ | DE | Health | Drug | Pharmaceutical Preparations | Davis Peter B | CA | O | VP,Finan | P | 24 | 4.79 | 0 | 5 | 5 | 110 | I | -49 | 22 | -45 | -32 | -33 | -28 | -20 | -13 | 0 | 11 | 1 | -10 | -51 | -78 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |